David A. Roth
2013 - Infinity Pharmaceuticals
In 2013, David A. Roth earned a total compensation of $1M as Chief Medical Officer at Infinity Pharmaceuticals.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Option Awards | $779,886 |
| Salary | $117,923 |
| Other | $1,476 |
| Total | $1,024,285 |
Roth received $779.9K in option awards, accounting for 76% of the total pay in 2013.
Roth also received $125K in bonus, $117.9K in salary and $1.5K in other compensation.
Rankings
In 2013, David A. Roth's compensation ranked 6,479th out of 12,286 executives tracked by ExecPay. In other words, Roth earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,479 out of 12,286 | 47th |
Division Manufacturing | 2,279 out of 4,612 | 51st |
Major group Chemicals And Allied Products | 678 out of 1,462 | 54th |
Industry group Drugs | 493 out of 1,156 | 57th |
Industry Pharmaceutical Preparations | 392 out of 890 | 56th |
Source: SEC filing on April 25, 2016.
Roth's colleagues
We found four more compensation records of executives who worked with David A. Roth at Infinity Pharmaceuticals in 2013.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019